IP Library Granted Patent US 11,591,578
Granted Patent B2
US 11,591,578 · App. 17/203,421 · Granted Feb 28, 2023

P450-BM3 variants with improved activity

Inventors: Robert Osborne (Raleigh, NC); Vesna Mitchell (Santa Clara, CA); Khin Yu Naing Htwe (Daly City, CA); Xiyun Zhang (Fremont, CA); Erika M. Milczek (New York, NY); Jeffrey C. Moore (Westfield, NJ)
Assignee: Codexis, Inc.
C12N9/0071C12N1/16C12N1/20C12N9/0042C12N15/52C12N15/63C12Y106/02004C12Y114/14001H05K999/99
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,591,578
App. No.
17/203,421
Filed
Mar 16, 2021
Granted
Feb 28, 2023
Kind
B2
Art Unit
1652
USPC
536/23.2
Abstract

The present invention provides improved P450-BM3 variants with improved activity. In some embodiments, the P450-BM3 variants exhibit improved activity over a wide range of substrates.

Claims (9)

1. A recombinant polynucleotide sequence encoding a recombinant cytochrome p450-BM3 variant comprising the sequence set forth in SEQ ID NO: 11.

2. An expression vector comprising the polynucleotide sequence of claim 1 .

3. The vector of claim 2 , wherein said polynucleotide sequence is operably linked with regulatory sequences suitable for expression of said polynucleotide sequence in a suitable host cell.

4. The vector of claim 3 , wherein said host cell is a prokaryotic or eukaryotic cell.

5. The vector of claim 4 , wherein said host cell is a prokaryotic cell.

6. The vector of claim 5 , wherein said host cell is E. coli.

7. A host cell comprising the vector of claim 2 .

8. A method for producing at least one recombinant cytochrome P450-BM3 variant comprising culturing a host cell comprising the vector of claim 2 under conditions such that at least one recombinant cytochrome P450-BM3 variant is produced by said host cell.

9. The method of claim 8 , further comprising the step of recovering said at least one recombinant cytochrome P450-BM3 variant.

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →